Viatris Stock: Is VTRS Outperforming the Healthcare Sector?

Valued at a market cap of $14.8 billion, Viatris Inc. (VTRS) is a healthcare company that operates in four segments: developed markets, Greater China, JANZ, and emerging markets. Based in Canonsburg, Pennsylvania, the company offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).

Companies valued at over $10 billion are typically classified as “large-cap stocks,” and Viatris fits the label perfectly with its market cap exceeding this threshold. The drug manufacturer is committed to advancing sustainable operations and innovative solutions to improve patient health and supplies medicines to patients in more than 165 countries and territories.